Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Emergent BioSolutions Inc.EBS · Entity 5902 | EVP, Chief HR Officer | February 28, 2023 | March 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Emergent BioSolutions Inc.
Report date February 28, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,824 |
Reported balance
After 2023-02-28 transaction · row 1
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 690 · Balance 62,824 F1: Represents shares of common stock withheld to pay taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock withheld to pay taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 2, 2023 14:42 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 690 | $12.38 | $8,542.20 |
DisclosureSEC source: 0001367644-23-000056 · wf-form4_167778612811435.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,824 F1 · shares: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 20:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 654 | $13.71 | $8,966.34 |
DisclosureSEC source: 0001367644-23-000038 · wf-form4_167754742435549.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,514 F1 · shares: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 352 | $14.30 | $5,033.60 |
DisclosureSEC source: 0001367644-23-000038 · wf-form4_167754742435549.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,168 F1 · shares: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 20:35 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 1,438 | $13.25 | $19,053.50 |
DisclosureSEC source: 0001367644-23-000016 · wf-form4_167607932918775.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,520 F2 · shares: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 20:35 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 61 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-23-000016 · wf-form4_167607932918775.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,958 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 3,723 shares of common stock, which is in excess of the 3,662 shares previously reported on February 25, 2020. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 18:45 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantEmployee Stock Options (Right to Buy) · Derivative | 24,164 | $41.38 Strike: $41.38 | $999,906.32 |
DisclosureSEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · derivative · entry 4 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,164 Underlying: Common Stock · 24,164 shares Expires 2029-02-28 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 18:45 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 12,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,458 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 18:45 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 24,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,375 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (6,042 shares) or on the day prior to the second anniversary date of the grant (18,125 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:45 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 561 | $39.64 | $22,238.04 |
DisclosureSEC source: 0001367644-22-000040 · wf-form4_164626467480687.xml · nonDerivative · entry 3 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,897 F3 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 17:19 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 590 | $42.47 | $25,057.30 |
DisclosureSEC source: 0001367644-22-000034 · wf-form4_164582755230958.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,208 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:19 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 344 | $42.23 | $14,527.12 |
DisclosureSEC source: 0001367644-22-000034 · wf-form4_164582755230958.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,798 F1 · security: Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:47 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 1,616 | $42.23 | $68,243.68 |
DisclosureSEC source: 0001367644-22-000014 · wf-form4_164574640464379.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,142 F2 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 18:47 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 1,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-22-000014 · wf-form4_164574640464379.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,758 F1 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 4,741 shares of common stock, which is in excess of the 3,483 shares previously reported on February 28, 2019. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 17:14 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 561 | $97.15 | $54,501.15 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 5 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,500 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 17:14 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 649 | $97.15 | $63,050.35 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 4 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,061 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantEmployee Stock Options (Right to Buy) · Derivative | 10,696 | $93.49 Strike: $93.49 | $999,969.04 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · derivative · entry 6 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,696 Underlying: Common Stock · 10,696 shares Expires 2028-02-23 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 619 | $93.49 | $57,870.31 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 3 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,710 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 2,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,329 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 2,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,655 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:22 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 2,042 | $123.45 | $252,084.90 |
DisclosureSEC source: 0001367644-21-000015 · wf-form4_161309656087627.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,981 F2 · security: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:22 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 2,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000015 · wf-form4_161309656087627.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,023 F1 · security: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 6,043 shares of common stock, which is in excess of the 4,029 shares previously reported on March 1, 2018. F1 · shares: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 6,043 shares of common stock, which is in excess of the 4,029 shares previously reported on March 1, 2018. Read SEC document |
| May 08, 2020 Filed May 12, 2020 16:30 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 237 | $79.25 | $18,782.25 |
DisclosureSEC source: 0001367644-20-000059 · wf-form4_158931538972314.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,009 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 27, 2020 Filed Feb 27, 2020 21:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 387 | $58.42 | $22,608.54 |
DisclosureSEC source: 0001367644-20-000020 · wf-form4_158285666341902.xml · nonDerivative · entry 5 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,246 F3 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 381 | $59.91 | $22,825.71 |
DisclosureSEC source: 0001367644-20-000020 · wf-form4_158285666341902.xml · nonDerivative · entry 4 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,633 F3 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 21:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 498 | $59.91 | $29,835.18 |
DisclosureSEC source: 0001367644-20-000020 · wf-form4_158285666341902.xml · nonDerivative · entry 3 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,014 F3 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantEmployee Stock Options (Right to Buy) · Derivative | 14,648 | $61.44 Strike: $61.44 | $899,973.12 |
DisclosureSEC source: 0001367644-20-000020 · wf-form4_158285666341902.xml · derivative · entry 6 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,225 Underlying: Common Stock · 14,648 shares Expires 2027-02-24 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 3,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000020 · wf-form4_158285666341902.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,512 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the three year period 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:24 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 3,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-20-000020 · wf-form4_158285666341902.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,850 F1 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| May 08, 2019 Filed May 10, 2019 17:18 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 237 | $47.49 | $11,255.13 |
DisclosureSEC source: 0001567619-19-010449 · doc1.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,188 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 28, 2019 Filed Feb 28, 2019 19:29 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 540 | $58.71 | $31,703.40 |
DisclosureSEC source: 0001567619-19-005676 · doc1.xml · nonDerivative · entry 5 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,425 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 19:29 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 387 | $57.98 | $22,438.26 |
DisclosureSEC source: 0001567619-19-005676 · doc1.xml · nonDerivative · entry 4 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,965 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 19:29 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantEmployee Stock Option (Right to Buy) · Derivative | 13,929 | $61.01 Strike: $61.01 | $849,808.29 |
DisclosureSEC source: 0001567619-19-005676 · doc1.xml · derivative · entry 6 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,929 Underlying: Common Stock · 13,929 shares Expires 2026-02-25 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 19:29 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 3,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005676 · doc1.xml · nonDerivative · entry 3 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,352 F3 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 19:29 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 3,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-005676 · doc1.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,869 F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 19:29 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 448 | $61.01 | $27,332.48 |
DisclosureSEC source: 0001567619-19-005676 · doc1.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,386 F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| May 08, 2018 Filed May 10, 2018 16:39 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 237 | $48.33 | $11,454.21 |
DisclosureSEC source: 0001140361-18-022813 · doc1.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,834 F1 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 17:05 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 540 | $49.97 | $26,983.80 |
DisclosureSEC source: 0001140361-18-011289 · doc1.xml · nonDerivative · entry 4 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,071 F1 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 17:05 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantEmployee Stock Option (right to buy) · Derivative | 16,116 | $49.64 Strike: $49.64 | $799,998.24 |
DisclosureSEC source: 0001140361-18-011289 · doc1.xml · derivative · entry 5 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,116 Underlying: Common Stock · 16,116 shares Expires 2025-02-26 F4 · derivative.exercise_date: Vests in three equal installments on February 26, 2019, February 26, 2020 and February 26, 2021. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 17:05 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | Tax withholdingCommon Stock | 387 | $49.64 | $19,210.68 |
DisclosureSEC source: 0001140361-18-011289 · doc1.xml · nonDerivative · entry 3 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,611 F1 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 17:05 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 4,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-011289 · doc1.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,998 F3 · shares: Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 17:05 UTC | Emergent BioSolutions Inc. EBS · Entity 5902 | GrantCommon Stock | 4,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-011289 · doc1.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,969 F1 · security: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.